About Hemos Global leader in recombinant keratin biomaterials
HEMOS (Chongqing) Bioscience Co., LTD. was established in 2017 and is headquartered in Chongqing. It is a biotechnology company specializing in the research, development, production, and sales of Recombinant Keratin.
Relying on the research team led by Professors Wang Bochu and Hao Shilei from the Bioengineering College of Chongqing University, the company has been deeply engaged in the field of recombinant keratin for over a decade. The research team has successfully deciphered and reconstructed the functional gene sequence of human keratin. Leveraging synthetic biology technologies, the company has become the first one in the world to achieve large-scale production of recombinant keratin.
Based on the efficacy and application scenarios of Recombinant Keratin, the company has established a comprehensive “experimental R&D - industrial application” full-chain system, focusing on providing high-performance biomaterials and solutions for the biomedical, cosmetics, and personal care sectors. We are committed to becoming a global benchmark enterprise in the application of recombinant keratin.
Hemos Bioscience Founded
Invention Patent and Technology
SCI Papers in the Global Recombinant Keratin Field
Development History We explore the limitless possibilities of Biomanufacturing.
2025
Expand the market and establish strategic partnerships with numerous leading domestic enterprises.
2024
Expand the applications of Recombinant Keratin in areas such as efficacy-based skincare, oral care, and hair care.
2023
Mapped out the functional spectrum of 17 human hair keratin-based wound-healing properties and published our findings in Advanced Functional Materials.
2021
Awarded the titles of “High-Tech Enterprise” and “Chongqing Municipal New R&D Institution”
2020
Transformed core technology and launched the first efficacy-focused product featuring Recombinant Keratin.
2019
Pioneered the large-scale production of Recombinant Keratin globally, broken through industrialization bottlenecks.
2018
Numerous research findings have been selected as Highly Cited Papers in ESI.
2017
The company was founded and established the world's first technology transfer platform for Recombinant Keratin.
2012
Chongqing University has successfully prepared recombinant keratin using synthetic biology technology.
2007
Professor Wang Bochu from Chongqing University has initiated research into keratin technology, based on the clinical value of "blood residue carbon"—its hemostatic and tissue-regenerating properties.
Qualifications and Honors We are building an open innovation ecosystem with global competitiveness.
- Qualification Certificate
- Certificate of Honor
High-tech Enterprise Certificate
Chongqing Municipality’s New-Type R&D Institutions
Quality Management System Certification Certificate
Second Prize, Enterprise Group, 4th Bishan District Innovation and Entrepreneurship Competition
First Excellent Award of the Western (Chongqing) Science City Dual-High Competition
8th China Innovation and Entrepreneurship Competition (Chongqing Division) Excellence Award
9th “Maker China” Chongqing Municipal SME Innovation and Entrepreneurship Competition – Enterprise Group, Excellence Award
2025 Bio-Manufacturing – Annual Innovative Enterprise
2025 VBEF Innovation Product Award – Innovative Medical Aesthetics and Ingredients
2024 Extraordinary Chinese Raw Materials 2025 Bio-Manufacturing—Annual Innovation Enterprise Raw Materials Award
2024 “Chongqing Good Gifts” Tourism Products (Cultural and Creative Products) Competition – Gold Award
First Prize in the Huaxin Smart Economy Industrial Park Technology Project Roadshow Event
The 20th (2025) New Economy Visionary Awards—Enterprise List: Outstanding Science and Technology Award
The 20th (2025) New Economy Visionary Awards—Product List: Innovative and High-Quality Products
Partner Choosing Hemos – Co-creating a Sustainable Future